Document Detail


The serotonin hypothesis of pulmonary hypertension revisited.
MedLine Citation:
PMID:  20204739     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The serotonin hypothesis of pulmonary arterial hypertension (PAH) arose after an outbreak of PAH in patients taking the anorexigenic drugs aminorex and dexfenfluramine. Both of these drugs are serotonin transporter (SERT) substrates and indirect serotinergic agonists. There is now a wealth of evidence to support a role for serotonin in the pathobiology of PAH. Synthesis of serotonin can occur in pulmonary artery endothelial cells by the enzyme tryptophan hydroxylase 1 (TPH1). Serotonin then acts at the 5-HT(1B) receptor and the SERT to mediate constriction and proliferation of pulmonary artery smooth muscle cells. Downstream signalling molecules which play a role in serotonin-induced constriction and proliferation include reactive oxygen species (ROS), Rho-kinase (ROCK) p38 and extracellular signal-regulated kinase (ERK). There is also evidence to suggest that serotonin may interact with the bone morphogenetic receptor type II (BMPRII) to provide a 'second hit' risk factor for PAH.
Authors:
Margaret R Maclean; Yvonne Dempsie
Related Documents :
697189 - Restrictive ventilatory defect in a patient with primary pulmonary hypertension.
20704929 - Mechanism of disease: pulmonary hypertension.
10993799 - Liposome-induced pulmonary hypertension: properties and mechanism of a complement-media...
20042709 - Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endot...
8083939 - Estimation of pulmonary artery pressure in patients with primary pulmonary hypertension...
445719 - The extraction of circulating catecholamines by the lungs in normal man and in patients...
25256179 - Intraplaque hemorrhage, fibrous cap status, and microembolic signals in symptomatic pat...
18662909 - Endovascular repair of a ruptured internal iliac arterial aneurysm with a novel applica...
19263359 - Crossed wernicke's aphasia after aneurysmal subarachnoid hemorrhage: a case report.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Advances in experimental medicine and biology     Volume:  661     ISSN:  0065-2598     ISO Abbreviation:  Adv. Exp. Med. Biol.     Publication Date:  2010  
Date Detail:
Created Date:  2010-03-05     Completed Date:  2010-04-26     Revised Date:  2014-02-19    
Medline Journal Info:
Nlm Unique ID:  0121103     Medline TA:  Adv Exp Med Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  309-22     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Appetite Depressants / adverse effects,  metabolism
Bone Morphogenetic Protein Receptors, Type II / genetics,  metabolism
Dexfenfluramine / adverse effects,  metabolism
Endothelial Cells / cytology,  metabolism
Humans
Hypertension, Pulmonary / chemically induced,  physiopathology*
Lung / blood supply,  metabolism,  pathology
Receptors, Serotonin / metabolism
Serotonin / metabolism*
Serotonin Plasma Membrane Transport Proteins / metabolism
Serotonin Receptor Agonists / adverse effects,  metabolism
Signal Transduction / physiology
Vasoconstriction / physiology
Grant Support
ID/Acronym/Agency:
G0801171//Medical Research Council
Chemical
Reg. No./Substance:
0/Appetite Depressants; 0/Receptors, Serotonin; 0/Serotonin Plasma Membrane Transport Proteins; 0/Serotonin Receptor Agonists; 333DO1RDJY/Serotonin; E35R3G56OV/Dexfenfluramine; EC 2.7.11.30/Bone Morphogenetic Protein Receptors, Type II

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rho kinase-mediated vasoconstriction in pulmonary hypertension.
Next Document:  Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vasc...